BUSINESS AREA INFECTION CONTROL HEALTHCARE GETINGE GROUP A G E N D A  Cash flow  Balance sheet items  Currency effects

BUSINESS AREA INFECTION CONTROL HEALTHCARE Net Debt Change in Net Debt Change in Net Debt before acquisition, currency and cash effect of restructuring cost Net Debt / EBITDA3,22,4 Net gearing1,570,93 Cash flow (MSEK) GETINGE GROUP

BUSINESS AREA INFECTION CONTROL HEALTHCARE Interest bearing loans  Balance as of December 31, 2007 is MSEK Funding of Boston acquisition is MSEK  Maturity profile of interest bearing loans is 7% in 2008, 7% in 2010, 78% in 2012, 3% in 2013 and 5% in 2015 Boston bridge financing expires July 2009  Currency level is SEK 40%, EUR 38%, GBP 11%, USD 6%, CAD 4%, and other 1% Boston debt is 100% denominated in USD  Average interest rates in 2007 were EUR 4,3%, USD 5,0%, SEK 4,2% and GBP 6,0%  Financial net at December 31 (MSEK) GETINGE GROUP CASH FLOW

GETINGE GROUP CASH FLOW (MSEK) cont +19% Operating cash flow before restructuring

Average days in accounts receivable (Exluding Huntleigh) Reduction 2007: 5 days Circa 230MSEK GETINGE GROUP CASH FLOW cont

Reduction 2007: 6 days Circa 240MSEK Average days in inventory (Exluding Huntleigh) GETINGE GROUP CASH FLOW cont

BUSINESS AREA INFECTION CONTROL HEALTHCARE Operating cash flow Capital expenditure, tangible assets Sale of tangible assets Capital expenditure, intangible assets Carried forward Cash flow (MSEK) GETINGE GROUP CASH FLOW (MSEK) cont

Capital expenditure -Tangible assets GETINGE GROUP CASH FLOW (MSEK) cont Gross capex 467m =2,8% of sales Gross capex 315m = 2,4% of sales Gross capex 236m = 2% of sales

BUSINESS AREA INFECTION CONTROL HEALTHCARE Brought forward Restructuring activities Net acquisition and divestments Financial net Paid taxes Dividend Other Change in net debt Cash flow (MSEK) GETINGE GROUP CASH FLOW (MSEK) cont

BUSINESS AREA INFECTION CONTROL HEALTHCARE New share issue GETINGE GROUP NEW SHARE ISSUE The Board of Getinge proposes a new share issue of approximately SEK 1,500 million for financing and continued expansion The proceeds of the issue are planned to: 1.Create financial scope for further business opportunities in the short term 2.Repay part of the bank loan raised in conjunction with the acquisition of Boston Scientific’s cardio and vascular surgical divisions

BUSINESS AREA INFECTION CONTROL HEALTHCARE GETINGE GROUP Forecast Tax rate28 %29 %27 % Tax charge (MSEK) Tax rate

BUSINESS AREA INFECTION CONTROL HEALTHCARE Medical Systems Extended Care Infection Control Total GoodwillGoodwillOtherOther additionsclosingintangiblesintangibles 2007balanceadditions closing 2007balance EBITA Medical Systems Extended Care 998 Infection Control 640 GETINGE GROUP GOODWILL & OTHER INTANGIBLES (MSEK)

GETINGE GROUP CURRENCY EFFECTS 2008 Negative currency effect in 2008 is circa 163 MSEK Currency rates used for group estimates USD6,47 EUR9,47 GBP12,91 CAD6,59 Net foreign volumes in 2008, million USD66 EUR88 GBP34 CAD20 Currency exposure at 5% change in currency rates, MSEK

BUSINESS AREA INFECTION CONTROL HEALTHCARE GETINGE GROUP CURRENCY EFFECTS 2008 (MSEK) MEDICAL SYSTEMS-91 EXTENDED CARE-30 INFECTION CONTROL-42 TOTAL-163

BUSINESS AREA INFECTION CONTROL HEALTHCARE GETINGE GROUP A G E N D A – 12.00Corporate Overview Johan Malmquist, CEO Johan Malmquist Financial Review Ulf Grunander, CFO Ulf Grunander – 13.00Lunch – 15.00Infection Control Christer Ström VP Infection Control Christer Ström Extended Care Michael Berg VP Extended Care Michael Berg – 15.30Coffee – 17.00Medical Systems Heribert Ballhaus VP Medical Systems Heribert Ballhaus Q&A